High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: An excellent prognostic indicator or a false friend?

Gastric Cancer

Volumn 16, Issue 4, 2013, Pages 513-520

  Rudno Rudzinska, Julia ^a   Kielan, Wojciech ^a   Grzebieniak, Zygmunt ^a   Dziegiel, Piotr ^a,b   Donizy, Piotr ^a   Mazur, Grzegorz ^a   Knakiewicz, Monika ^a   Frejlich, Ewelina ^a   Halon, Agnieszka ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

D2 40; Gastric cancer; LYVE 1; VEGF C; VEGF D

Indexed keywords

LYMPHATIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; MEMBRANE PROTEIN; PODOPLANIN; UNCLASSIFIED DRUG; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY INFILTRATE; LYMPH VESSEL; LYMPH VESSEL DENSITY; LYMPHANGIOGENESIS; LYMPHATIC PARAMETERS; MALE; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; SURVIVAL RATE; TUMOR INVASION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D; VESICULAR TRANSPORT PROTEINS;

EID: 84885960881     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-012-0216-8     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin. 2005;55:74-108.
2. Matsubara J, Yamada Y, Nakajima TE, Kato K, Hamaguchi T, Shirao K, et al. Clinical significance insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer. Oncology. 2008;74:76-83.
3. Amioka T, Kitadai Y, Tanaka S. Vascular endothelial growth factor C expression predicts lymph node metastasis of human gastric carcinoma invading the submucosa. Eur J Cancer. 2002;38:1413-9.
4. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial. Lancet. 2010;376:687-97.
5. Yonemura Y, Fushida S, Bando E, Kinoshita K, Miwa K, Endo Y, et al. T: lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR3) 3 in gastric cancer. Eur J Cancer. 2001;37:918-23.
6. Ferrara N, Gerber H-P, Le Couter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-76.
7. Hirakawa S, Brown LF, Kodama S. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood. 2007;109(3):1010-7.
8. Gou HF, Chen XC, Zhu J, Jiang M, Yang Y, Cao D, et al. Expression of Coc-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications. J Exp Clin Cancer Res. 2011;28(30):14.
9. Kozlowski M, Naumnik W, Niklinski J, Milewski R, Dziegielewski P, Laudanski J. Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with resected esophageal cancer. Neoplasma. 2011;58(4):311-9.
10. Huang KJ, Sui LH. The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer. Med Oncol 2012;29(1):318-23. doi: 10.1007/s12032-010-9817-4.
11. Sinn V, Darb-Esfahni S, Wirtz RM, Faggad A, Wechert W, Buckendahl AC, et al. Vascular endothelial growth factor C mRNA expression is a prognostic factor in epithelial ovarian cancer as detected by kinetic RT-PCR in formalin-fixed paraffin-embedded tissue. Virchows Arch. 2009;455(6):461-7.
12. Nakamura Y, Yasuoka H, Tsujimoto M, Imabun S, Nakahara M, Nakako H, et al. Lymph vessel density correlates with nodal status, VEGF-C expression and prognosis in breast cancer. Breast Cancer Res Treat. 2005;91(2):125-31.
13. Liu X, Sun XD, Wu JM. Expression and significance of VEGF C and FLT-4 in gastric cancer. World J Gastroenterol. 2004;10(3):352-5.
14. Yonemura Y, Endo Y, Fujita H. Role of vascular endothelial growth factor C expression in development of lymph node metastasis in gastric cancer. Clin Cancer Res. 1999;5:1823-9.
15. Jutter S, Wibman C, Jons T. Vascular endothelial growth factor D and its receptor VEGFR3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol. 2006;24:228-9.
16. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18(1):4-25.
17. Coskun U, Yamac D. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. J Surg Res. 2009;164:1-6.
18. Jackson DG, Prevo R, Clasper S, Banejri S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 2001;22(6):317-21.
19. Zeng Y, Opeskin K, Horvath LG. Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate. 2005;65:222.
20. Gordon EJ, Gale NW, Harvey NL. Expression of the hyaluronan receptor LYVE-1 is not restricted to the lymphatic vasculature: LYVE-1 is also expressed on embryonic blood vessels. Dev Dyn. 2008;237:1901-9.
21. Jackson DG. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. Acta Pathol Microbiol Immunol Scand. 2004;112:526-38.
22. Raica M, Cimpean AM, Ribatti D. The role of podoplanin in tumor progression and metastasis. Anticancer Res. 2008;28:2997-3006.
23. Wicki A, Christofori G. The potential role of podoplanin in tumor invasion. Br J Cancer. 2007;96(1):1-5.
24. Weidner N, Semple J, Welich W, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
25. Remmele W, Stenger HE. Vorschlag zur einheitlicchen Definition eines Immunreaktiven Score (IRS) fuer den immunohistochemischen Oestrogenrezeptor- Nachweis (ER-ICA) im Mammarkarzinomgewebe. Pathologe. 1987;8:138-40.
26. Fujimoto A, Ishikawa Y, Ishii T. Significance of lymphatic invasion on regional lymph node metastasis in early gastric cancer using LYVE-1. Immunohistochemical analysis. Am J Clin Pathol. 2001;127(1):1T-7T.
27. Nakamura KK. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer. J Clin Pathol. 2006;59:77-82.
28. Gao P, Zhou GY, Zhang QH, Xiang L, Zhang SL, Li C, Sun YL. Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma. Cancer Lett. 2008;263(2):223-30.
29. Coskun U, Yamac D. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. J Surg Res. 2009;164:110-5.
30. Hye U, Oh YH, Park YW. Correlation of vascular endothelial growth factor-D expression and VEGFR 3-positive vessel density with lymph node metastasis in gastric carcinoma. J Korean Med. 2008;23:292-7.
31. Yashiro M, Shinto O, Nakamura K, Tendo M, Matsuoka T, Matsuzaki T, Kaizaki R, Ohira M, Miwa A, Hirakawa K. Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model. Br J Cancer. 2009;101:1100-6.
32. Ichikura T, Tomimatsu S, Ohkura E. Prognostic significance of the expression of vascular endothelial growth factor and VEGF C in gastric carcinoma. J Surg Oncol. 2001;78(2):132-7.
33. Ko YH, Jung CK, Lee MA, Byun JH, Kang JH, Lee KY, Jo KH, Wang YP, Hong YS. Clinical significance of vascular endothelial growth factors (VEGF)-C and -D in resected non-small cell lung cancer. Cancer Res Treat. 2008;40(3):133-40. doi: 10.4143/crt.2008.40.3.133.
34. Shimizu K, Kubo H, Yamaguchi K. Suppression of VEGFR3 signaling inhibits lymph node metastasis In gastric cancer. Cancer Sci. 2004;95:328-33.